EMMA International hires Jacob Griesbach for business development
EMMA International has named Jacob Griesbach as a business development specialist to expand client relationships and support growth across the life sciences sector. The hire adds healthcare sales experience as the consulting firm looks to deepen its regulatory, quality and compliance work with drug, biotech and medtech customers.
Why it matters: - EMMA International is adding sales and relationship-building experience as it tries to expand across the life sciences industry. - The hire is aimed at strengthening revenue growth, partnerships and client engagement in a sector facing complex regulatory, quality and compliance demands.
What happened: - EMMA International named Jacob Griesbach as a Business Development Specialist. - The announcement was made Sept. 24, 2026. - Griesbach joins the Miami-based company as it works to broaden its client reach.
The details: - Griesbach brings healthcare sales and business development experience across pharmaceutical, biologics and medical device markets. - His background includes new business development, strategic account management and customer engagement programs. - He has worked with Integrated Delivery Networks, health systems, hospitals, physician groups and post-acute care providers nationwide. - EMMA International says Griesbach has helped organizations improve patient outcomes by connecting them with therapies, medical technologies and clinical solutions. - Carmine Jabri, CEO of EMMA International, said Griesbach’s healthcare background and relationship-focused approach will help the company expand its reach. - Griesbach will oversee strategies to improve revenue streams, build key partnerships and drive business development initiatives.
Between the lines: - The hire suggests EMMA International is leaning more heavily on business development to convert its regulatory and compliance expertise into new client growth. - The company is positioning its consulting services as a response to rising operational and regulatory complexity across life sciences. - The announcement also signals that EMMA International wants broader market visibility after more than a decade in business.
What's next: - Griesbach is expected to help introduce more organizations to EMMA International’s regulatory, quality, compliance and operational services. - EMMA International is likely to keep building relationships with companies navigating complex life sciences challenges. - The company plans to use the new role to support continued growth and market expansion.
The bottom line: - EMMA International is betting that an experienced healthcare sales executive can help turn industry know-how into new business.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Sci-Tech News Network
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.